BE827926A - Antibiotique - Google Patents

Antibiotique

Info

Publication number
BE827926A
BE827926A BE155402A BE155402A BE827926A BE 827926 A BE827926 A BE 827926A BE 155402 A BE155402 A BE 155402A BE 155402 A BE155402 A BE 155402A BE 827926 A BE827926 A BE 827926A
Authority
BE
Belgium
Prior art keywords
antibiotic
Prior art date
Application number
BE155402A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE827926A publication Critical patent/BE827926A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BE155402A 1974-04-20 1975-04-14 Antibiotique BE827926A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB17410/74A GB1508977A (en) 1974-04-20 1974-04-20 Beta-lactam antibiotic from streptomyces clavuligerus

Publications (1)

Publication Number Publication Date
BE827926A true BE827926A (fr) 1975-10-14

Family

ID=10094711

Family Applications (1)

Application Number Title Priority Date Filing Date
BE155402A BE827926A (fr) 1974-04-20 1975-04-14 Antibiotique

Country Status (6)

Country Link
AT (1) AT352270B (cs)
BE (1) BE827926A (cs)
CS (1) CS231157B2 (cs)
GB (1) GB1508977A (cs)
SU (1) SU648117A3 (cs)
ZA (1) ZA752492B (cs)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2646004A1 (de) * 1975-10-13 1977-04-21 Beecham Group Ltd Clavulansaeureaether, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4098897A (en) 1975-04-14 1978-07-04 Beecham Group Limited Anti bacterial agents
US4571392A (en) * 1977-05-19 1986-02-18 Beecham Group Limited 6-Substituted derivatives of clavulanic acid
US5734048A (en) * 1995-05-16 1998-03-31 Chong Kun Dang Corp. Process for manufacturing clavulanic acid salt
EP2589663A1 (en) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Process for production of clavulanic acid

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008525A3 (en) * 1978-08-25 1980-05-28 Beecham Group Plc Pharmaceutical compositions and process for their preparation
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
EP0026044B1 (en) * 1979-08-24 1983-06-08 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
US4454069A (en) * 1979-08-24 1984-06-12 Beecham Group Limited Clavulanic acid salts and their preparation from the tertiary butyl amine salt
NZ213963A (en) * 1984-10-27 1989-01-06 Antibioticos Sa Production of clavulanic acid
US5288861A (en) * 1987-01-29 1994-02-22 Beecham Group Plc Potassium clavulanate in rosette form
US5750685A (en) * 1987-01-29 1998-05-12 Smithkline Beecham, P.L.C. Process for preparing potassium clavulanate in rossette form
ES2008418A6 (es) * 1987-01-29 1989-07-16 Beecham Group Plc Un procedimiento para la obtencioon de nueva forma cristalina del clavulanato de potasio y de composiciones del mismo.
AT400033B (de) 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
DE4318916A1 (de) * 1993-06-07 1994-12-08 Bayer Ag Cyclobutylazole
GB9401969D0 (en) * 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB9408117D0 (en) 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9424950D0 (en) * 1994-12-10 1995-02-08 Smithkline Beecham Plc Novel process
JPH11501023A (ja) * 1995-02-25 1999-01-26 スパーコート リミテッド クラブラン酸塩
SI9500074A (en) 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500265A1 (en) * 1995-08-28 1997-02-28 Lek Tovarna Farmacevtskih Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
ES2101658B1 (es) * 1995-11-23 1998-03-01 Antibioticos Sa Nuevo procedimiento de produccion de acido clavulanico y sus sales.
ZA975198B (en) * 1996-06-13 1997-12-15 Smithkline Beecham Corp Improved process for preparing potassium clavulanate.
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
AT404728B (de) * 1996-11-27 1999-02-25 Biochemie Gmbh Verfahren zur herstellung von clavulansäure-aminsalzen
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6489319B2 (en) 1999-08-16 2002-12-03 Revaax Pharmaceuticals, Llc Neurotherapeutic use of carboxypeptidase inhibitors
US6426342B2 (en) 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
ATE518540T1 (de) 1999-08-16 2011-08-15 Revaax Pharmaceuticals Llc Beta-lactam verbindung enthaltende neurotherapeutische zusammensetzung
DK1284978T4 (da) 2000-05-13 2009-01-05 Smithkline Beecham Plc Fremgangsmåde til oprensning af et salt af clavulansyre
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
ES2357595B1 (es) * 2009-10-02 2012-03-15 Instituto Mediterr�?Neo Para El Avance De La Biotecnolog�?A Y La Investigación Sanitaria (Fundación Imabis) Composición de �?cido clavul�?nico y uso para el diagnóstico en alergolog�?a.
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
CN115433701B (zh) * 2022-11-08 2023-03-17 南京农业大学 一株变形杆菌及其菌剂和在降解头孢类抗生素中的应用

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098897A (en) 1975-04-14 1978-07-04 Beecham Group Limited Anti bacterial agents
US4428937A (en) 1975-04-14 1984-01-31 Beecham Group Limited Antibacterial agents
DE2646004A1 (de) * 1975-10-13 1977-04-21 Beecham Group Ltd Clavulansaeureaether, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4571392A (en) * 1977-05-19 1986-02-18 Beecham Group Limited 6-Substituted derivatives of clavulanic acid
US5734048A (en) * 1995-05-16 1998-03-31 Chong Kun Dang Corp. Process for manufacturing clavulanic acid salt
EP2589663A1 (en) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Process for production of clavulanic acid
WO2013064687A2 (en) 2011-11-04 2013-05-10 Lek Pharmaceuticals D.D. Process for production of clavulanic acid

Also Published As

Publication number Publication date
CS231157B2 (en) 1984-10-15
AT352270B (de) 1979-09-10
CS272175A2 (en) 1984-02-13
GB1508977A (en) 1978-04-26
SU648117A3 (ru) 1979-02-15
ZA752492B (en) 1976-06-30
ATA298575A (de) 1979-02-15

Similar Documents

Publication Publication Date Title
BE827926A (fr) Antibiotique
HU174930B (hu) Ingaljator
DK198075A (da) Planetgear
BE836210A (fr) Polyorethannes aniomiques
DK240275A (da) Tufteapparat
HU172091B (hu) Sposob poluchenija proizvodnykh n-skobka-1-benzil-pirrolidinil-2-alkil-skobka zakryta-benzamida
BE833375A (fr) Secoprostaglandines
DK180675A (da) Phenylalkylaminer
HU174585B (hu) Upakovochnoe sredstvo dlja dlinnorazmernykh izdelij
IT1026120B (it) Acooppiamento kmagnetico
SE7513570L (sv) Antibiotikum
JPS5110034A (ja) Konbain
SE7514033L (sv) Nytt antibiotiskt komplex
BE829199A (fr) Composition antibiotique
FI54847C (fi) Ransoneringsbehaollare foer djurutfodringsanordningar
DK234275A (da) Harkroller
FI56049B (fi) Cylinderlaos
DK137092C (da) Skyderist
JPS5110001A (ja) Torakutayorootarinodoryokudentatsukeiniokeru jointokakudochoseisochi
BE827408A (fr) Ureidocephalosporines antibiotiques
BE825385A (fr) Elektrofotografisch filmdeel
BE836121A (fr) Monochromones
HU173242B (hu) Sposob poluchenija novykh anlogov prostaglandinov
HU173838B (hu) Sposob poluchenija novykh proizvodnykh metano-dibenzo-ciklogeptapirrola
BE835382A (fr) Soupirail

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: BEECHAM GROUP LTD

Effective date: 19950414